STOCK TITAN

Erasca (NASDAQ: ERAS) foundation plans 8,333-share Rule 144 stock sale

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Erasca Foundation has filed a notice of proposed sale under Rule 144 covering 8,333 shares of Erasca, Inc. common stock. The shares are to be sold through Merrill Lynch on NASDAQ, with an aggregate market value of $68,573.87 and an approximate sale date of 01/15/2026. The filing notes that 283,711,805 shares of this class were outstanding.

The securities to be sold come from a larger block of 10,193,557 common shares that the foundation acquired as a donation from Erasca, Inc. on 07/20/2021. Over the past three months, Erasca Foundation has already sold 8,333 shares on each of 10/15/2025, 11/17/2025, and 12/15/2025, with gross proceeds of $20,591.33, $21,626.50, and $30,438.69, respectively.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does Erasca (ERAS) Form 144 filing disclose?

The Form 144 shows that Erasca Foundation plans to sell 8,333 shares of Erasca, Inc. common stock on or around 01/15/2026 through Merrill Lynch on NASDAQ, with an aggregate market value of $68,573.87.

Who is selling Erasca, Inc. shares and through which broker?

The seller is Erasca Foundation, and the planned sale of common shares will be executed through Merrill Lynch at its Rancho Santa Fe, California office, with the shares listed on NASDAQ.

How many Erasca, Inc. shares has Erasca Foundation sold recently?

Over the past three months, Erasca Foundation sold 8,333 common shares on each of 10/15/2025, 11/17/2025, and 12/15/2025, for gross proceeds of $20,591.33, $21,626.50, and $30,438.69, respectively.

How did Erasca Foundation acquire the Erasca, Inc. shares being sold?

The foundation acquired the shares via a donation from Erasca, Inc. on 07/20/2021, receiving 10,193,557 common shares, which form the source of the current and recent sales.

What is the class of Erasca, Inc. securities covered by this Form 144?

The filing covers common stock of Erasca, Inc., listed for trading on the NASDAQ exchange.

How many Erasca, Inc. common shares are outstanding according to the filing?

The notice states that 283,711,805 shares of Erasca, Inc. common stock were outstanding, providing context for the size of the planned and recent sales.

Erasca, Inc.

NASDAQ:ERAS

ERAS Rankings

ERAS Latest News

ERAS Latest SEC Filings

ERAS Stock Data

2.71B
227.87M
11.68%
81.93%
6.6%
Biotechnology
Pharmaceutical Preparations
Link
United States
SAN DIEGO